TAKARA BIO INC. Logo

TAKARA BIO INC.

Provides life science research tools, gene therapies, and CDMO services for improving human health.

4974 | T

Overview

Corporate Details

ISIN(s):
JP3460200003
LEI:
Country:
Japan
Address:
草津市野路東七丁目4番38号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Takara Bio Inc. is a global biotechnology company dedicated to improving human health through innovative life science research tools and gene therapies. The company supplies a comprehensive portfolio of reagents, kits, instruments, and services to researchers focused on gene discovery, regulation, and function. Its offerings support a wide range of applications, including single-cell analysis, sequencing, immune profiling, and stem cell research. Additionally, Takara Bio is a key player in the development of cutting-edge medical technologies, focusing on gene and cell therapies for cancer and other diseases. The company also provides contract development and manufacturing (CDMO) services, supporting partners in the production of therapeutic products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-12 03:15
Registration Form
確認書
Japanese 8.1 KB
2025-11-12 03:13
Interim / Quarterly Report
半期報告書-第24期(2025/04/01-2026/03/31)
Japanese 191.8 KB
2025-06-30 02:46
AGM Information
臨時報告書
Japanese 27.5 KB
2025-06-20 07:27
Registration Form
確認書
Japanese 8.1 KB
2025-06-20 07:26
Governance Information
内部統制報告書-第23期(2024/04/01-2025/03/31)
Japanese 23.6 KB
2025-06-20 07:24
Annual Report
有価証券報告書-第23期(2024/04/01-2025/03/31)
Japanese 1.7 MB
2025-05-13 09:11
Board/Management Information
臨時報告書
Japanese 21.8 KB
2024-11-11 02:37
Regulatory Filings
確認書
Japanese 8.1 KB
2024-11-11 02:36
Interim / Quarterly Report
半期報告書-第23期(2024/04/01-2025/03/31)
Japanese 167.8 KB
2024-07-01 04:07
AGM Information
訂正臨時報告書
Japanese 36.9 KB
2024-06-28 04:30
AGM Information
臨時報告書
Japanese 27.3 KB
2024-06-27 06:14
Governance Information
内部統制報告書-第22期(2023/04/01-2024/03/31)
Japanese 22.7 KB
2024-06-27 06:13
Registration Form
確認書
Japanese 8.1 KB
2024-06-27 06:12
Annual Report
有価証券報告書-第22期(2023/04/01-2024/03/31)
Japanese 1.8 MB
2024-02-14 07:42
Report Publication Announcement
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all TAKARA BIO INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TAKARA BIO INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TAKARA BIO INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Vaxcyte, Inc. Logo
A clinical-stage company developing broad-spectrum vaccines for bacterial infectious diseases.
United States of America
PCVX
VENTURE LIFE GROUP PLC Logo
Develops, manufactures, and distributes consumer self-care products and medical devices globally.
United Kingdom
VLG
Ventyx Biosciences, Inc. Logo
Clinical-stage biopharma developing oral therapies for autoimmune, inflammatory & neuro diseases.
United States of America
VTYX
Verastem, Inc. Logo
Develops cancer medicines targeting the RAS/MAPK pathway, with an approved therapy for ovarian cancer.
United States of America
VSTM
Vericel Corp Logo
Develops autologous cell therapies for sports medicine and severe burn care markets.
United States of America
VCEL
Verona Pharma plc Logo
Develops innovative therapies for chronic respiratory diseases like COPD and asthma.
United States of America
VRNA
Verrica Pharmaceuticals Inc. Logo
Develops topical therapies for skin diseases like molluscum contagiosum and common warts.
United States of America
VRCA
VERTEX PHARMACEUTICALS INC / MA Logo
Develops transformative medicines for serious diseases, specializing in cystic fibrosis.
United States of America
VRTX
VERU INC. Logo
Biopharma firm developing drugs for cardiometabolic and inflammatory diseases.
United States of America
VERU
Vetoquinol SA Logo
Develops and markets veterinary drugs and products for companion animals and livestock worldwide.
France
VETO

Talk to a Data Expert

Have a question? We'll get back to you promptly.